Revenues up 58.9%, Net Income up 41.7%
Board declares dividend of $0.05/share

Revenues up 58.9%, Net Income up 41.7%
Board declares dividend of $0.05/share
Conference call to be on Monday, July 13, 2015, at 4:15 p.m. EDT
Enhances synergy between predicted properties and GastroPlus™ Version 9.0 modeling capabilities
Important new features expand market for flagship software product
Dr. Michael Lawless to transition to Marketing and Sales Team.
Dr. Vijay Gombar joins the Company as leader of the Cheminformatics Studies Team.
Final report of second quarter financial results
Cognigen quarterly profits rise
Consolidated net revenues up 48.4%; second quarter net income increases 19.8%
Final report of first quarter financial results after Cognigen merger; net revenues up 54%; gross profit increased 41%
Conference Call to be on Wednesday, January 14, at 4:15 PM ET
Preliminary revenues increase 50% to first quarter record $3.96 million
Full Fiscal Year Pharmaceutical Software and Services up 13.8%, Fourth Quarter Revenues up 27.4%
Conference Call to be on Tuesday, November 25, 2014, at 4:15 PM EST